Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patientsElisabetta Schiaroli, Daniela Francisci, Sara Pierucci et al.|Journal of Clinical Virology|2023Cited by 3
UV-C Irradiation Effectiveness on Mpox-Virus-Contaminated SurfacesAnna Gidari, Daniela Francisci, Samuele Sabbatini et al.|Pathogens|2026Cited by 1
EFFICACY OF MONOCLONAL ANTIBODIES ASSOCIATION IN PRESENCE OF TWO SARS-COV-2 DOMINANT VARIANT OF CONCERN. COMPARATIVE STUDY VERSUS MONOTHERAPY AGAINST A SINGLE VARIANT: A REAL EXPERIENCE IN UMBRIA, ITALY.Elisabetta Schiaroli, Daniela Francisci, Chiara Busti et al.|Mediterranean Journal of Hematology and Infectious Diseases|2022Cited by 0